| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 117, 77-83, Copyright © 1985 by Endocrine Society
ARTICLES |
DR Clemmons
Platelet-derived growth factor (PDGF) is a potent mitogen for smooth muscle cells, but to detect maximal stimulation by PDGF, the cells must be incubated with plasma. Somatomedin-C (Sm-C), a peptide growth factor that is present in plasma, has been shown to interact with PDGF synergistically to stimulate DNA synthesis in cultured fibroblasts. These studies were designed to test the hypothesis that PDGF interacted with Sm-C to stimulate smooth muscle cell replication and to compare the response of this cell type to that of fibroblasts. When PDGF or Sm- C was added individually to smooth muscle cell cultures, each growth factor induced only minimal increases in [3H]thymidine incorporation into DNA (i.e. PDGF, 3,400 +/- 1,120 to 54,900 +/- 1,550 cpm; Sm-C, 3,400 +/- 1,120 to 10,950 +/- 980 cpm). In contrast, addition of increasing concentrations of Sm-C to cultures that were continuously exposed to PDGF in the presence of Sm-C-deficient plasma resulted in a synergistic increase in [3H]thymidine incorporation (3,400 +/- 1,120 to 54,500 +/- 1,800 cpm; P less than 0.001). To determine if Sm-C was required for smooth muscle cell replication, cultures were sequentially exposed to PDGF, followed by Sm-C-deficient plasma. The rate at which the non-Sm-C-exposed cells synthesized DNA was retarded compared to that of cells exposed to Sm-C-containing plasma; however, 68% nuclear labeling was present after 44 h of incubation. To exclude the possibility that some cellular secretory product was substituting for Sm-C, the medium was changed every 2 h and replaced by fresh Sm-C- deficient medium. Using these test conditions, exposure to PDGF and Sm- C-deficient plasma induced only 11% labelling. Readdition of pure Sm-C to this medium restored nuclear labeling to 82% at 44 h. Other variables that appeared to modulate the cellular response to Sm-C were culture density and simultaneous PDGF exposure. Sm-C and PDGF both appear to be potent mitogens for porcine aortic smooth muscle cells, and when added together to quiescent cultures, their effects are synergistic. Smooth muscle cells appear to require Sm-C to initiate DNA synthesis, and in its absence produce a Sm-like factor that can partially compensate for Sm-C deficiency and allow replication.
This article has been cited by other articles:
![]() |
G. Zhao, R. L. Sutliff, C. S. Weber, J. Wang, J. Lorenz, R. J. Paul, and J. A. Fagin Smooth Muscle-Targeted Overexpression of Insulin-Like Growth Factor I Results in Enhanced Vascular Contractility Endocrinology, February 1, 2001; 142(2): 623 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imai and D. R. Clemmons Roles of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase Pathways in Stimulation of Vascular Smooth Muscle Cell Migration and Deoxyriboncleic Acid Synthesis by Insulin-Like Growth Factor-I Endocrinology, September 1, 1999; 140(9): 4228 - 4235. [Abstract] [Full Text] |
||||
![]() |
P. R. Standley, T. J. Obards, and C. L. Martina Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: implications in vascular hyperplasia Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E697 - E705. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zheng, C. Duan, and D. R. Clemmons The Effect of Extracellular Matrix Proteins on Porcine Smooth Muscle Cell Insulin-like Growth Factor (IGF) Binding Protein-5 Synthesis and Responsiveness to IGF-I J. Biol. Chem., April 10, 1998; 273(15): 8994 - 9000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jacot and D. R. Clemmons Effect of Glucose on Insulin-Like Growth Factor Binding Protein-4 Proteolysis Endocrinology, January 1, 1998; 139(1): 44 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krettek, G. Fager, H. Lindmark, C. Simonson, and F. Lustig Effect of Phenotype on the Transcription of the Genes for Platelet-Derived Growth Factor (PDGF) Isoforms in Human Smooth Muscle Cells, Monocyte-Derived Macrophages, and Endothelial Cells In Vitro Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2897 - 2903. [Abstract] [Full Text] |
||||
![]() |
C. Duan, S. B. Hawes, T. Prevette, and D. R. Clemmons Insulin-like Growth Factor-I (IGF-I) Regulates IGF-binding Protein-5 Synthesis through Transcriptional Activation of the Gene in Aortic Smooth Muscle Cells J. Biol. Chem., February 23, 1996; 271(8): 4280 - 4288. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delafontaine, X. P. Meng, L. Ku, and J. Du Regulation of Vascular Smooth Muscle Cell Insulin-like Growth Factor I Receptors by Phosphorothioate Oligonucleotides J. Biol. Chem., June 16, 1995; 270(24): 14383 - 14388. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du and P. Delafontaine Inhibition of Vascular Smooth Muscle Cell Growth Through Antisense Transcription of a Rat Insulin-Like Growth Factor I Receptor cDNA Circ. Res., June 1, 1995; 76(6): 963 - 972. [Abstract] [Full Text] |
||||
![]() |
A. Gockerman and D. R. Clemmons Porcine Aortic Smooth Muscle Cells Secrete a Serine Protease for Insulin-like Growth Factor Binding Protein-2 Circ. Res., April 1, 1995; 76(4): 514 - 521. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |